Healthcare Surveillance Authority (HSA) announced that it will initiate the complaint in the case of company, which is suspected from illegal earning on the export of tissues from dead donors abroad. HSA has terminated the contract with Company Tissue Research Institute in April. Suspicion arises from the fact that company, which had a permit from Ministry of Health for operation of tissue institution, did not process the tissues by itself and has not concluded the contract for processing of taken tissues with other healthcare provider. This happened despite the facts that act on health care commands it.